H&R GmbH & Co. KGaA Announces 2023 Annual Financial Results

H&R GmbH & Co. KGaA released its financial outcomes for the year 2023, confirming its preliminary figures with an EBITDA of EUR 92.7 million. The company also declared its intention to propose a dividend payment of €0.10 per share to its Annual General Meeting. Notably, the firm's sales revenues reached EUR 1,352.3 million, experiencing a decrease from the prior year mainly due to alterations in price and volume factors.

The reported operating cash flow stood at 119.1 million, significantly higher than the previous year, underlining the company's robust cash-generating capability amidst fluctuating market conditions. In addition, the financial summary highlighted a consolidated net income attributable to shareholders of EUR 10.6 million, down from the previous year. The earnings per share followed suit, settling at €0.28, reflecting the challenges faced during the financial term.

Breaking down the performance by segments, the ChemPharm Refining reported sales revenues of 828.2 million, with the ChemPharm Sales and Plastics segments showing mixed results. Despite a tough year, H&R GmbH & Co. KGaA remains optimistic, projecting an EBITDA between €90.0 million and €110.0 million for 2024 and remains open to adjusting its forecasts in response to ongoing business developments.